THE ASTIS TRIAL: AUTOLOGOUS STEM CELL TRANSPLANTATION VERSUS IV PULSE CYCLOPHOSPHAMIDE IN POOR PROGNOSIS SYSTEMIC SCLEROSIS, FIRST RESULTS